Reuters logo
BRIEF-Spectral provides regulatory update on its PMA submission for Toraymyxin
2017年9月21日 / 中午12点14分 / 1 个月前

BRIEF-Spectral provides regulatory update on its PMA submission for Toraymyxin

Sept 21 (Reuters) - Spectral Medical Inc

* Spectral provides regulatory update on its PMA submission for Toraymyxin(TM)

* Spectral Medical Inc - ‍has been engaged in an ongoing interactive review process with FDA​

* Spectral Medical Inc - ‍expects to receive more detailed feedback from FDA on PMA submission in Q4 of 2017​

* Spectral Medical -continues to be involved in a review process with FDA and Health Canada for its SAM continuous renal replacement therapy instrument Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below